Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvo save search
Wegovy® approved in the US for cardiovascular risk reduction in people with overweight or obesity and established cardiovascular disease
Published: 2024-03-08 (Crawled : 19:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
| Email alert
Add to watchlist
wegovy obesity disease approved risk cardiovascular
Highlights to be presented at Novo Nordisk’s Capital Markets Day 2024
Published: 2024-03-07 (Crawled : 07:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 6.97%
H: 3.63%
C: 1.86%
day
Novo Nordisk A/S: Semaglutide 1.0 mg demonstrates 24% reduction in the risk of kidney disease-related events in people with type 2 diabetes and chronic kidney disease in the FLOW trial
Published: 2024-03-05 (Crawled : 10:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -1.33%
H: 0.46%
C: -1.27%
disease kidney risk trial diabetes flow
Novo Nordisk A/S - share repurchase programme
Published: 2024-03-04 (Crawled : 14:30) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 2.5%
H: 1.13%
C: 0.49%
repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2024-02-26 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.2%
H: 0.78%
C: 0.24%
repurchase
Insulin Pen Global Market Outlook Report 2024-2028: Current Market Size and Revenue Growth Prospects for Insulin Pens, with Market Share Analysis by Type, Onset Time, End User and Geographical Region
Published: 2024-02-23 (Crawled : 17:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.37%
H: 0.58%
C: 0.58%
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 0.0%
H: 1.93%
C: 1.27%
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.68%
H: 0.4%
C: -0.18%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.89%
H: 0.4%
C: 0.17%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: 0.0%
report revenue global insulin growth market
Notice for the Annual General Meeting of Novo Nordisk A/S
Published: 2024-02-21 (Crawled : 14:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -2.02%
H: 1.67%
C: 1.62%
meeting
Novo Nordisk A/S – Share repurchase programme
Published: 2024-02-19 (Crawled : 14:30) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
| Email alert
Add to watchlist
repurchase
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2024-02-14 (Crawled : 12:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 0.43%
H: 2.35%
C: 2.31%
Novo Nordisk A/S - share repurchase programme
Published: 2024-02-12 (Crawled : 17:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.64%
H: 0.35%
C: 0.09%
repurchase
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2024-02-12 (Crawled : 12:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.64%
H: 0.35%
C: 0.09%
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2024-02-08 (Crawled : 15:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.51%
H: 0.49%
C: 0.29%
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2024-02-06 (Crawled : 19:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.54%
H: 2.31%
C: 1.44%
Novo Holdings invests in Manipal Hospitals, a leading private hospital chain in India
Published: 2024-02-06 (Crawled : 08:00) - prnewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: -0.61%
hospital india
Novo Nordisk A/S - share repurchase programme
Published: 2024-02-06 (Crawled : 08:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: -0.61%
repurchase
Novo Holdings to Acquire Catalent
Published: 2024-02-05 (Crawled : 12:00) - biospace.com/
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 2.37%
H: 1.9%
C: 1.61%
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: -0.79%
H: 0.0%
C: -0.8%
CTLT | $55.8 -0.29% 0.0% 1M
|
Health Technology
|
| O: 8.81%
H: 1.5%
C: 0.86%
acquire
Novo Nordisk to acquire three fill-finish sites from Novo Holdings A/S in connection with the Catalent, Inc. transaction
Published: 2024-02-05 (Crawled : 11:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 2.37%
H: 1.9%
C: 1.61%
CTLT | $55.8 -0.29% 0.0% 1M
|
Health Technology
|
| O: 8.81%
H: 1.5%
C: 0.86%
acquire
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2024-02-01 (Crawled : 20:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -1.75%
H: 0.74%
C: -0.05%
Novo Nordisk files annual report with the SEC
Published: 2024-01-31 (Crawled : 12:30) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 2.87%
H: 3.54%
C: 2.31%
report
Novo Nordisk's sales increased by 31% in Danish kroner and by 36% at constant exchange rates to DKK 232.3 billion in 2023
Published: 2024-01-31 (Crawled : 07:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: 2.87%
H: 3.54%
C: 2.31%
sales
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.